157 related articles for article (PubMed ID: 30094101)
1. Bufalin inhibits glycolysis-induced cell growth and proliferation through the suppression of Integrin β2/FAK signaling pathway in ovarian cancer.
Li H; Hu S; Pang Y; Li M; Chen L; Liu F; Liu M; Wang Z; Cheng X
Am J Cancer Res; 2018; 8(7):1288-1296. PubMed ID: 30094101
[TBL] [Abstract][Full Text] [Related]
2. Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells.
Yang Y; Cao Y; Chen L; Liu F; Qi Z; Cheng X; Wang Z
Cancer Med; 2018 Sep; 7(9):4610-4618. PubMed ID: 30094960
[TBL] [Abstract][Full Text] [Related]
3. Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway.
Liu F; Tong D; Li H; Liu M; Li J; Wang Z; Cheng X
Oncotarget; 2016 Feb; 7(8):8896-907. PubMed ID: 26758421
[TBL] [Abstract][Full Text] [Related]
4. Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells.
Chen L; Cheng X; Tu W; Qi Z; Li H; Liu F; Yang Y; Zhang Z; Wang Z
Cell Oncol (Dordr); 2019 Oct; 42(5):679-690. PubMed ID: 31325096
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin suppresses the growth and proliferation of breast and cervical cancer cell lines by inhibiting integrin β5-mediated glycolysis.
Wang S; Xie J; Li J; Liu F; Wu X; Wang Z
Am J Cancer Res; 2016; 6(5):1108-17. PubMed ID: 27294003
[TBL] [Abstract][Full Text] [Related]
7. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
8. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades.
Siu MKY; Jiang YX; Wang JJ; Leung THY; Han CY; Tsang BK; Cheung ANY; Ngan HYS; Chan KKL
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212816
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying the antimetastatic activity of bufalin.
Wang J; Xia Y; Zuo Q; Chen T
Mol Clin Oncol; 2018 May; 8(5):631-636. PubMed ID: 29732152
[TBL] [Abstract][Full Text] [Related]
10. Bufalin inhibits glioblastoma growth by promoting proteasomal degradation of the Na
Lan YL; Wang X; Lou JC; Xing JS; Yu ZL; Wang H; Zou S; Ma X; Zhang B
Biomed Pharmacother; 2018 Jul; 103():204-215. PubMed ID: 29653366
[TBL] [Abstract][Full Text] [Related]
11. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
[TBL] [Abstract][Full Text] [Related]
12. Paris saponins Ⅶ inhibits glycolysis of ovarian cancer via the RORC/ACK1 signaling pathway.
Wu Z; Yuan C; Zhang Z; Wang M; Xu M; Chen Z; Tian J; Cao W; Wang Z
Biochem Pharmacol; 2023 Jul; 213():115597. PubMed ID: 37196681
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells.
Mukherjee A; Ma Y; Yuan F; Gong Y; Fang Z; Mohamed EM; Berrios E; Shao H; Fang X
Neoplasia; 2015 Sep; 17(9):723-734. PubMed ID: 26476080
[TBL] [Abstract][Full Text] [Related]
14. Bufalin reverses intrinsic and acquired drug resistance to cisplatin through the AKT signaling pathway in gastric cancer cells.
Zhao H; Zhao D; Jin H; Li H; Yang X; Zhuang L; Liu T
Mol Med Rep; 2016 Aug; 14(2):1817-22. PubMed ID: 27357249
[TBL] [Abstract][Full Text] [Related]
15. Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis In Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways.
Wu SH; Hsiao YT; Kuo CL; Yu FS; Hsu SC; Wu PP; Chen JC; Hsia TC; Liu HC; Hsu WH; Chung JG
Am J Chin Med; 2015; 43(6):1247-64. PubMed ID: 26446205
[TBL] [Abstract][Full Text] [Related]
16. The sodium pump α1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway.
Lan YL; Zou YJ; Lou JC; Xing JS; Wang X; Zou S; Ma BB; Ding Y; Zhang B
Cell Biol Toxicol; 2019 Dec; 35(6):521-539. PubMed ID: 30739221
[TBL] [Abstract][Full Text] [Related]
17. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
18. Bufalin induces G2/M phase arrest and triggers autophagy via the TNF, JNK, BECN-1 and ATG8 pathway in human hepatoma cells.
Hsu CM; Tsai Y; Wan L; Tsai FJ
Int J Oncol; 2013 Jul; 43(1):338-48. PubMed ID: 23677253
[TBL] [Abstract][Full Text] [Related]
19. Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221.
Zhang J; Sha J; Zhou Y; Han K; Wang Y; Su Y; Yin X; Hu H; Yao Y
Evid Based Complement Alternat Med; 2016; 2016():7319464. PubMed ID: 28074104
[TBL] [Abstract][Full Text] [Related]
20. Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells.
Hong SH; Choi YH
Oncol Rep; 2012 Jan; 27(1):114-20. PubMed ID: 21901250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
